What this is. Short, honest write-ups of new studies at the intersection of obesity, GLP-1 weight-loss medications, and kidney health — each one explained in plain language, with the same discipline every time: what it shows, who it applies to, and what it does not prove.
Why it exists. New results in this area come out constantly, and the headlines are often ahead of the evidence. Study Radar is the antidote: a steady, source-bound feed that treats a lab-marker result differently from a hard-outcome result, and never turns a relative-risk headline into a promise.
How to read a Radar post
Every post follows the same six-part format, so you always know what you’re looking at:
- The study in one sentence — what was done.
- What was measured — and crucially, whether the endpoint was a hard outcome (like kidney failure) or a surrogate (like a lab number).
- What it means for patients — the practical takeaway.
- What it does not mean — the honest limits, stated plainly.
- Clinician note — three lines of technical detail with an evidence tag.
- Reference — so you can check it yourself.
If a post is about a surrogate endpoint, we say so up top. If the population studied doesn’t match yours, we say that too.
Get the Radar in your inbox
📬 New studies on weight loss drugs and kidney health, explained monthly. One email a month. No hype, no selling — just what changed and what it means. Sign up for the newsletter →
Latest posts
[Radar posts appear here as they are published. First posts to be added — e.g., FLOW long-term data, tirzepatide CKD trial read-outs, KDIGO/CKM guideline updates.]
Related, deeper reading
- Semaglutide (Ozempic/Wegovy) and Your Kidneys — the full pillar.
- Tirzepatide (Mounjaro/Zepbound) and Your Kidneys — the full pillar.
- Curriculum for clinicians — the structured, source-bound overview.
- How this site is written and reviewed — editorial policy and disclosures.
Educational information only — not medical advice. Study Radar explains research; it is not a recommendation for your care. Talk with your own clinician about what any study means for you.